Recent Quotes
My Watchlist
Indicators
REW 40 Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by EverythingALS

News headline image
EverythingALS and ALS United Partner to Expand National Coverage of ALS Clinical Trial Matching with SAVA AI
From EverythingALS
Via Business Wire
News headline image
EverythingALS and Vision 2030 Announce Expanded International Scientific Advisory Board to Support ALS Research Collaboration
From EverythingALS
Via Business Wire
News headline image
EverythingALS and Vision 2030 Invest in Allen Institute Initiative to Accelerate ALS Research
From EverythingALS
Via Business Wire
News headline image
EverythingALS Launches AI called SAVA AI to Match Patients with Clinical Trials
From EverythingALS
Via Business Wire
News headline image
EverythingALS Launches New Mobile App: A Comprehensive Research and Life Navigation Tool for the ALS Community
From EverythingALS
Via GlobeNewswire
News headline image
EverythingALS Launches the Vision 2030 AI Hub: Charting the Path to an ALS Cure and Advancing Neurodegenerative Disease Research
From EverythingALS
Via GlobeNewswire
News headline image
EverythingALS Releases First Open Data From the Austen Speech Study
From EverythingALS
Via GlobeNewswire
News headline image
EverythingALS Announces Student Fellow Scholarship Awards and Expanded Student Ambassador Program aims to accelerate ALS Research
From EverythingALS
Via GlobeNewswire
News headline image
New $400,000 Grant Supports EverythingALS.org and Mass General Hospital (MGH) to Develop NeuroLens, a Digital Diagnostics technology initiative for early detection of Amyotrophic Lateral Sclerosis (ALS)
From EverythingALS
Via Business Wire
News headline image
EverythingALS and CureALS Join Forces to Discover a Cure for ALS
From EverythingALS
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.